Background: Hypersalivation and drooling are commonly reported in clozapine-treated patients. Current management strategies have been evaluated using subjective measures. Many case reports describe the successful use of atropine in the treatment of the condition.
Aims: To measure the effect and safety of sublingual atropine on nocturnal unstimulated saliva secretion. Secondary aims were to evaluate the patient's satisfaction with the atropine effect on hypersalivation (or sialorrhea), drooling, and sleep.
Method: Twenty-one clozapine-treated patients with hypersalivation, or drooling, were randomised to take a single 600-μg dose of sublingual atropine drops or a matching placebo. The saliva secretion was measured over 5 min at baseline and 2 h after the administration of the study medication.
Results: Sublingual atropine reduced the saliva secretion significantly more than the placebo (mean difference = - 57.21%, 95% CI: - 104.30, - 10.11, P = 0.02). A significant decrease in standing pulse rate was recorded in the participants in the atropine group (- 5.8 (- 9.54, - 2.15), P = 0.002). Subjectively, more patients in the atropine group found their pillow to have less saliva the following morning and found their sleep to be better.
Conclusions: Sublingual atropine drops significantly reduces nocturnal unstimulated clozapine-induced saliva secretion. More research is required to compare the effect of sublingual atropine with other anticholinergic medications and different dosage forms.
Trial Registration: ACTRN12618000051246.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00213-020-05627-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Report: Painful left bundle branch block syndrome complicated with vasovagal syncope.
Front Cardiovasc Med
January 2025
Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Background: Painful left bundle branch block (LBBB) syndrome is an uncommon disease that is defined as intermittent episodes of angina associated with simultaneous LBBB changes on an electrocardiogram (ECG) with the absence of flow-limiting coronary artery disease or ischemia on functional testing. Vasovagal syncope (VVS) is the most common cause of syncope and can be provoked by sublingual nitroglycerin (NTG). Herein, we report a case of painful LBBB syndrome complicated with VVS, which was misdiagnosed as acute coronary syndrome and cardiogenic shock.
View Article and Find Full Text PDFSublingual administration of atropine eye drops for treating sialorrhea after stroke: A randomized controlled trial.
J Stroke Cerebrovasc Dis
December 2024
Traditional Chinese Medicine Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang City, China. Electronic address:
Article Synopsis
- Sialorrhea, or excessive saliva production, is common in stroke patients with swallowing disorders, and atropine sulfate can reduce saliva by blocking certain receptors.
- A study at Xiangyang No. 1 People's Hospital tested sublingual atropine eye drops on 100 stroke patients, comparing results with a control group receiving standard rehabilitation.
- Results showed a significant improvement in sialorrhea scores for the group using atropine, with no notable increase in adverse events, indicating that this method is effective, safe, and non-invasive for treatment.
Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges.
Psychopharmacol Bull
August 2024
Deep, MD, Psychiatry, Professor, Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
We discuss a case with off-label sublingual administration of atropine for clozapine-induced sialorrhea (CIS) after failure of two commonly used agents to manage CIS. Atropine had a demonstrable efficacy, as measured by means of sialometry conducted before and after its administration. The salivary rate, initially measured at 0.
View Article and Find Full Text PDFArticle Synopsis
- * He was treated with sublingual atropine eye drops, which reduced the need for intravenous atropine.
- * This treatment allowed for quick recovery, enabling him to walk without help and be discharged.
Parotid hypersalivation after inferior salivatory nucleus glutamate/NMDA receptor excitation in the rat.
Physiol Behav
June 2024
Department of Psychobiology and Mind, Brain and Behaviour Research Centre (CIMCYC), University of Granada, Granada 18071, Spain. Electronic address:
Although salivation is essential during eating behavior, little is known about the brainstem centers that directly control the salivary glands. With regard to the inferior salivatory nucleus (ISN), the site of origin of the parasympathetic preganglionic cell bodies that innervate the parotid glands, previous anatomical studies have located it within the rostrodorsal medullary reticular formation. However, to date there is no functional data that shows the secretory nature of the somas grouped in this region.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!